1041 Results for "

Stat

" in MedChemExpress (MCE) Product Catalog:
Products (1041)

1041 Results for "Stat" in MCE Product Catalog:

314
314 Publications Verification
Art. -Nr.: HY-13818
CAS. Nr.: 19983-44-9
Reinheit:  99.58%
Target:  

STAT Apoptosis

Forschungsgebiete:  

Inflammation/Immunology Cancer

Stattic is a potent STAT3 inhibitor and inhibits STAT3 phosphorylation (at Y705 and S727) . Stattic inhibits the binding of a high affinity phosphopeptide for the SH2 domain of STAT3 . Stattic ameliorates the renal dysfunction in Alport syndrome (AS) mice .
loading...
    loading...
307
307 Cited Publications
Art. -Nr.: HY-10201
CAS. Nr.: 284461-73-0
Reinheit:  99.92%
Synonyms: Bay 43-9006
Sorafenib (Bay 43-9006) is a potent oral active multikinase inhibitor. Sorafenib blocks autophosphorylation and activity of receptor tyrosine kinases (VEGFR-2, VEGFR-3) and RAF family kinases, thereby suppressing the RAF/MEK/ERK and PI3K/Akt pathways, inhibiting STAT3 phosphorylation, and selectively inhibiting the MAPK pathway in cancer cells. Sorafenib induces cell cycle arrest, autophagy, apoptosis, and PARP cleavage, reduces Bcl-2, Bcl-XL, cyclin D1 levels, and activates Bak and Bax. Sorafenib inhibits tumor growth and metastasis in mouse and rat models. Sorafenib can be used for cancer research, such as colon, breast, non-small-cell lung cancer (NSCLC), ovarian, pancreatic, melanoma, colorectal and hepatocellular carcinoma .
loading...
    loading...
307
307 Cited Publications
Art. -Nr.: HY-10201A
CAS. Nr.: 475207-59-1
Reinheit:  99.75%
Synonyms: Bay 43-9006 tosylate
Sorafenib (Bay 43-9006) tosylate is a potent oral active multikinase inhibitor. Sorafenib blocks autophosphorylation and activity of receptor tyrosine kinases (VEGFR-2, VEGFR-3) and RAF family kinases, thereby suppressing the RAF/MEK/ERK and PI3K/Akt pathways, inhibiting STAT3 phosphorylation, and selectively inhibiting the MAPK pathway in cancer cells. Sorafenib tosylate induces cell cycle arrest, autophagy, apoptosis, and PARP cleavage, reduces Bcl-2, Bcl-XL, cyclin D1 levels, and activates Bak and Bax. Sorafenib tosylate inhibits tumor growth and metastasis in mouse and rat models. Sorafenib tosylate can be used for cancer research, such as colon, breast, non-small-cell lung cancer (NSCLC), ovarian, pancreatic, melanoma, colorectal and hepatocellular carcinoma .
loading...
    loading...
171
171 Cited Publications
Art. -Nr.: HY-12000
CAS. Nr.: 133550-30-8
Reinheit:  99.86%
Synonyms: Tyrphostin AG490; Tyrphostin B42
Target:  

EGFR STAT JAK Autophagy

Forschungsgebiete:  

Cancer

AG490 (Tyrphostin AG490) is a tyrosine kinase inhibitor that inhibits EGFR, Stat-3 and JAK2/3.
loading...
    loading...
132
132 Cited Publications
Art. -Nr.: HY-15244
CAS. Nr.: 1217486-61-7
Reinheit:  99.88%
Synonyms: BYL-719
Alpelisib (BYL-719) is an orally active PI3Kα-selective inhibitor that blocks the conversion of PIP2 to PIP3, thereby inhibiting pathways including PI3K/AKT/mTOR, MAPK/ERK, Notch and JAK-STAT. Alpelisib also induces apoptosis, G0/G1 phase arrest and senescence; it significantly inhibits the proliferation, self-renewal, stemness and epithelial-mesenchymal transition (EMT) of tumor cells, reduces cancer stem cell populations and decreases the expression of stem cell markers. Alpelisib not only enhances the sensitivity to Eribulin (HY-13442) and exerts a synergistic effect with Paclitaxel (HY-B0015), but may also induce drug resistance by upregulating the SGK3/GSK3β/β-catenin signaling pathway. Alpelisib can be applied to research related to breast cancer, gastric cancer and lipomas associated with PTEN hamartoma tumor syndrome .
loading...
    loading...
132
132 Cited Publications
Art. -Nr.: HY-15244A
CAS. Nr.: 1584128-91-5
Synonyms: BYL-719 hydrochloride
Alpelisib (BYL-719) hydrochloride is an orally active PI3Kα-selective inhibitor that blocks the conversion of PIP2 to PIP3, thereby inhibiting pathways including PI3K/AKT/mTOR, MAPK/ERK, Notch and JAK-STAT. Alpelisib hydrochloride also induces apoptosis, G0/G1 phase arrest and senescence; it significantly inhibits the proliferation, self-renewal, stemness and epithelial-mesenchymal transition (EMT) of tumor cells, reduces cancer stem cell populations and decreases the expression of stem cell markers. Alpelisib hydrochloride not only enhances the sensitivity to Eribulin (HY-13442) and exerts a synergistic effect with Paclitaxel (HY-B0015), but may also induce drug resistance by upregulating the SGK3/GSK3β/β-catenin signaling pathway. Alpelisib hydrochloride can be applied to research related to breast cancer, gastric cancer and lipomas associated with PTEN hamartoma tumor syndrome .
loading...
    loading...
111
111 Cited Publications
Art. -Nr.: HY-B0069
CAS. Nr.: 21679-14-1
Synonyms: F-ara-A; NSC 118218
Fludarabine (NSC 118218) is a DNA synthesis inhibitor and a fluorinated purine analogue with antineoplastic activity in lymphoproliferative malignancies. Fludarabine inhibits the cytokine-induced activation of STAT1 and STAT1-dependent gene transcription in normal resting or activated lymphocytes .
loading...
    loading...
98
98 Cited Publications
Art. -Nr.: HY-P1061
CAS. Nr.: 867021-83-8
Target:  

STAT Amyloid-β

Forschungsgebiete:  

Neurological Disease

Colivelin is a brain penetrant neuroprotective peptide and a potent activator of STAT3, suppresses neuronal death by activating STAT3 in vitro . Colivelin exhibits long-term beneficial effects against neurotoxicity, Aβ deposition, neuronal apoptosis, and synaptic plasticity deficits in neurodegenerative disease . Colivelin has the potential for the treatment of alzheimer's disease and ischemic brain injury
loading...
    loading...
98
98 Cited Publications
Art. -Nr.: HY-P1061A
CAS. Nr.: 2803948-60-7
Target:  

STAT Amyloid-β Apoptosis

Forschungsgebiete:  

Neurological Disease

Colivelin TFA is a brain penetrant neuroprotective peptide and a potent activator of STAT3, suppresses neuronal death by activating STAT3 in vitro . Colivelin TFA exhibits long-term beneficial effects against neurotoxicity, Aβ deposition, neuronal apoptosis, and synaptic plasticity deficits in neurodegenerative disease . Colivelin TFA has the potential for the treatment of alzheimer's disease and ischemic brain injury .
loading...
    loading...
67
67 Cited Publications
Art. -Nr.: HY-15146
CAS. Nr.: 501919-59-1
Reinheit:  98.35%
Synonyms: S3I-201
Target:  

STAT

Forschungsgebiete:  

Cancer

NSC 74859 (S3I-201) is a selective Stat3 inhibitor with an IC50 of 86 μM .
loading...
    loading...
57
57 Cited Publications
Art. -Nr.: HY-100614
CAS. Nr.: 919486-40-1
Reinheit:  98.99%
Target:  

STAT

Forschungsgebiete:  

Inflammation/Immunology Cancer

AS1517499 is a potent and brain-permeable STAT6 phosphorylation inhibitor with an IC50 of 21 nM.
loading...
    loading...
47
47 Cited Publications
Art. -Nr.: HY-N0174
CAS. Nr.: 35825-57-1
Synonyms: Cryptotanshinon; Tanshinone c
Cryptotanshinone is a natural compound extracted from the root of Salvia miltiorrhiza Bunge that shows antitumor activities. Cryptotanshinone inhibits STAT3 with an IC50 of 4.6 μM.
loading...
    loading...
46
46 Cited Publications
Art. -Nr.: HY-15205
CAS. Nr.: 888216-25-9
Reinheit:  99.94%
Synonyms: STA-9090
Target:  

HSP Apoptosis

Forschungsgebiete:  

Cancer

Ganetespib (STA-9090) is a heat shock protein 90 (HSP90) inhibitor which exhibits potent cytotoxicity in a wide variety of hematological and solid tumor cell lines. Ganetespib has antiangiogenic effects in colorectal cancer mediated through inhibition of HIF-1α and STAT3 .
loading...
    loading...
44
44 Cited Publications
Art. -Nr.: HY-10074
CAS. Nr.: 507475-17-4
Reinheit:  98.60%
Target:  

IKK STAT Apoptosis

Forschungsgebiete:  

Inflammation/Immunology Cancer

TPCA-1 is a potent and selective inhibitor of IKK-2 with IC50 of 17.9 nM. TPCA-1 is an effective inhibitor of STAT3 phosphorylation, DNA binding, and transactivation.
loading...
    loading...
43
43 Cited Publications
Art. -Nr.: HY-N0193
CAS. Nr.: 88495-63-0
Artesunate is an inhibitor of both STAT-3 and exported protein 1 (EXP1).
loading...
    loading...
43
43 Cited Publications
Art. -Nr.: HY-B0497
CAS. Nr.: 50-65-7
Synonyms: BAY2353
Forschungsgebiete:  

Infection Cancer

Niclosamide (BAY2353) is an orally active antihelminthic agent used in parasitic infection research . Niclosamide is a STAT3 inhibitor with an IC50 of 0.25 μM in HeLa cells . Niclosamide has biological activities against cancer, inhibits DNA replication in Vero E6 cells .
loading...
    loading...
43
43 Cited Publications
Art. -Nr.: HY-B0497C
CAS. Nr.: 1420-04-8
Synonyms: BAY2353 olamine
Forschungsgebiete:  

Infection Cancer

Niclosamide (BAY2353) olamine is an orally active antihelminthic agent used in parasitic infection research . Niclosamide olamin is a STAT3 inhibitor with an IC50 of 0.25 μM in HeLa cells . Niclosamide olamin has biological activities against cancer, and inhibits DNA replication in Vero E6 cells .
loading...
    loading...
41
41 Cited Publications
Art. -Nr.: HY-15312
CAS. Nr.: 857064-38-1
Reinheit:  99.77%
Target:  

STAT JAK Apoptosis

Forschungsgebiete:  

Cancer

WP1066 is an inhibitor of JAK2 and STAT3, and also shows effect on STAT5 and ERK1/2, without affecting JAK1 and JAK3. WP1066 can cross the blood-brain barrier[1][2][3][4].
loading...
    loading...
36
36 Cited Publications
Art. -Nr.: HY-112288
CAS. Nr.: 432001-19-9
Reinheit:  99.90%
Synonyms: TTI-101
C188-9 (TTI-101) is a STAT3 inhibitor with a Kd value of 4.7 nM. C188-9 targets the SH2 domain of STAT3, blocks the processes of STAT3 ligand binding, receptor recruitment, homodimerization and phosphorylation, and regulates STAT3-mediated genes associated with tumorigenesis and radioresistance. C188-9 regulates STAT1-mediated genes related to radioresistance and reduces the activation level of STAT1. C188-9 downregulates the expression of DNMT1, enhances DAC-induced demethylation and re-expression of RASSF1A, and simultaneously potentiates the anti-tumor effect of DAC on pancreatic cancer cells. C188-9 inhibits both anchorage-dependent and anchorage-independent growth of cancer cells, induces Apoptosis, blocks the growth of tumor xenografts, and suppresses muscle atrophy. C188-9 maintains muscle mass, increases body weight and improves grip strength in tumor-bearing mice. C188-9 can be used in research related to head and neck squamous cell carcinoma, pancreatic cancer, sepsis-related skeletal muscle wasting, non-small cell lung cancer, acute myeloid leukemia and cancer cachexia .
loading...
    loading...
35
35 Cited Publications
Art. -Nr.: HY-117287
CAS. Nr.: 1609392-27-9
Reinheit:  99.87%
Synonyms: BMS-986165
Deucravacitinib (BMS-986165) is an orally active allosteric inhibitor of tyrosine kinase 2 (TYK2), with an IC50 of 0.2 nM and a Ki of 0.02 nM against the JH2 domain of TYK2, and it exhibits selectivity over other JAK subtypes and most of the kinome. Deucravacitinib blocks IL-23, IL-12, p-STAT1/3 and Type I IFN signaling, and inhibits Th17/Th1-mediated psoriasis inflammation . Deucravacitinib can be used in research related to moderate-to-severe plaque psoriasis, inflammatory bowel disease and systemic lupus erythematosus .
loading...
    loading...